Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Baxter CEO steps down

  • News

Executive Summary

Baxter CEO Harry Kraemer plans to leave the company as soon as a successor is found. Baxter has been dogged by problems related to its plasma business and the adoption rate of the anti-hemophilic factor VIIIAdvate. Former Johnson & Johnson President James Lenehan is the most widely speculated candidate; other potential contenders are Integra LifeSciences CEO Stuart Essig and Garrett Capital Advisors Managing Partner Jim Connelly. Baxter has hired Heidrick & Struggles to head up the search...

Table

View full table

Tags:
Latest Headlines

EMA Pilots Partnering With Companies To Gain Efficiencies In Preparing Drug Assessment Reports

US FDA’s Vaccine Office Emerges From Non-COVID-19 Backlog

AstraZeneca’s Farxiga Authorized Generic Aims To Broaden Access As Medicare Price Cut Looms

US FDA Adcomm Reform: Does Listening Session Suggest No Major Near-Term Changes?

See All
UsernamePublicRestriction

Register

PS043244

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By